Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Controlled Trial to Evaluate the Efficacy of a Dual-Modality Immunotherapy (Oral Immunomodulator and Vaginal Ovule) for Human Papillomavirus (HPV) Clearance

NCT07735039 is registered in ClinicalTrials.gov with Dr. Lutfi Kirdar Kartal Training and Research Hospital as lead sponsor.

NCT NCT07735039
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07735039 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Controlled Trial to Evaluate the Efficacy of a Dual-Modality Immunotherapy (Oral Immunomodulator and Vaginal Ovule) for Human Papillomavirus (HPV) Clearance
Lead sponsor
Dr. Lutfi Kirdar Kartal Training and Research Hospital
Phase
Not applicable
Overall status
Active, not recruiting
Start date
April 28, 2026
Completion date
August 24, 2026
Enrollment
76 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cervical intraepithelial neoplasia (cin), human papillomavirus infection, low-grade squamous intraepithelial lesions